RobertFDonnellMD

Associate Professor, Urology, Vice President and Chief Medical Informatics Officer, Associate Dean Medical College of Wisconsin

Dr. Donnell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
9200 W Wisconsin Ave
Department Of Urology
Milwaukee, WI 53226
Phone+1 414-805-0805

Fax+1 414-805-0771

Medical College of Wisconsin Affiliated HospitalsResidency, Urology, 1987 - 1992
University of Wisconsin School of Medicine & Public HealthClass of 1987

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow (FACS) American College of Surgeons

PubMed

39 citations
Effects of 100 and 300 Units of Onabotulinum Toxin A on Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Phase II Randomized Clinical Trial
E. David Crawford, Kathryn Hirst, John W. Kusek, Robert F. Donnell, Steven A. Kaplan
The Journal of Urology. 2011-09-01
762 citations
Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia
Kevin T. McVary, Claus G. Roehrborn, Andrew L. Avins, Michael J. Barry, Reginald C. Bruskewitz
The Journal of Urology. 2011-05-01
56 citations
Benign prostate hyperplasia: a review of the year's progress from bench to clinic.
Robert F. Donnell
Current Opinion in Urology. 2011-01-01

CMIO Robert Donnell, M.D. On the Journey of Clinical Decision Support at Froedtert HealthMay 31st, 2016

Chemoprevention of Prostate Cancer with Selenium and Vitamin E Alone or in Combination, Phase III (SELECTSouthwest Oncology Group/National Cancer Institute2000–2012
MIST - II BOTOX injection of the Prostate for the relief of LUTS from Benign Prostate HyperplasiaNational Institutes of Health2003–2009
Prostate Cancer Prevention Trials using Finasteride (Proscar): A Phase 3 StudyNational Cancer Institute1992–2004
Effect of Testosterone on bone density/hypogonadal men Source:National Institute On Aging: National Institutes of Health1993–1996